시장보고서
상품코드
1784049

세계의 예방 헬스케어 기술 및 서비스 시장

Preventive Healthcare Technologies and Services

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 185 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

예방 헬스케어 기술 및 서비스 세계 시장은 2030년까지 5억 2,110만 달러에 달할 전망

2024년에 2억 9,790만 달러로 추정되는 예방 헬스케어 기술 및 서비스 세계 시장은 2024년부터 2030년까지 CAGR 9.8%로 성장하여 2030년에는 5억 2,110만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 조기 발견 및 스크리닝 기술은 CAGR 8.8%를 기록하며 분석 기간 종료시에는 1억 9,970만 달러에 달할 것으로 예측됩니다. 만성질환 관리 기술 분야의 성장률은 분석 기간 동안 CAGR 8.9%로 추정됩니다.

미국 시장은 8,120만 달러로 추정, 중국은 CAGR 13.2%로 성장 예측

미국의 예방 헬스케어 기술 및 서비스 시장은 2024년에 8,120만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 1억 520만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 13.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 7.1%와 8.5%로 예측됩니다. 유럽에서는 독일이 CAGR 7.6%로 성장할 것으로 예측됩니다.

세계 예방 의료 기술 및 서비스 시장 - 주요 동향 및 촉진요인 정리

예방 의료가 전 세계 의료 산업에서 성장세를 보이고 있는 이유는 무엇일까?

예방 의료 기술 및 서비스는 의료 시스템이 질병 부담을 줄이고, 환자 결과를 개선하고, 의료 비용을 절감하기 위해 예방적 조치로 전환함에 따라 크게 성장하고 있습니다. 질병 치료에 중점을 둔 소극적 헬스케어 모델과 달리 예방적 헬스케어는 당뇨병, 심혈관질환, 암 등 만성질환을 예방하기 위해 조기 진단, 위험 평가, 생활습관 개선에 중점을 둡니다. 생활습관병이 점점 더 만연해지면서 정부, 보험사, 의료 서비스 제공자는 예방접종 프로그램, 조기 검진 도구, 맞춤형 건강 모니터링 솔루션 등 예방 전략을 우선순위에 두고 있습니다. 디지털 헬스 플랫폼, 웨어러블 기기, 인공지능 기반 진단의 등장은 예방 의료에 대한 접근성과 정확성을 더욱 높이고 있습니다. 또한, 소비자들의 건강에 대한 인식이 높아지면서 웰빙을 중시하고, 기술을 활용하여 건강 상태를 추적하고 관리하기 위해 노력하고 있습니다. 공공 및 민간 의료 부문이 예방 조치에 대한 투자를 지속하면서 예방 의료 기술 및 서비스 세계 시장이 확대되고 의료 서비스 제공의 미래를 재구성할 것입니다.

예방적 헬스케어의 성장을 가로막는 과제는 무엇일까?

이러한 장점에도 불구하고, 예방 의료 기술의 보급은 여러 가지 도전에 직면해 있습니다. 주요 장벽 중 하나는 첨단 진단 도구와 건강 검진 서비스에 드는 비용이며, 특히 저소득층의 경우 모든 사람이 감당할 수 있는 금액이 아닐 수 있습니다. 예방 의료에 대한 표준화된 정책이나 상환 구조가 없기 때문에 보험 제공자는 예방보다 치료를 우선시하는 경우가 많아 예방 의료에 대한 접근성이 더욱 제한됩니다. 또한, 많은 환자들이 검진을 미루거나 초기 증상을 무시하거나 정기적인 건강검진을 받지 않는 경우가 많아 환자의 예방적 건강관리 대책에 대한 순응도가 여전히 우려되고 있습니다. 또한, 전자건강기록(EHR), 디지털 헬스케어 기기, AI 기반 분석 간의 상호운용성 문제를 해결해야 하기 때문에 여러 플랫폼 간 예방적 헬스케어 데이터 통합의 복잡성 또한 의료 서비스 제공자에게 도전이 되고 있습니다. 또한 백신, 예방약, 디지털 헬스 모니터링에 대한 잘못된 정보와 회의적인 시각이 시장 침투를 지연시킬 가능성도 있습니다. 이러한 문제를 해결하기 위해서는 정부의 지원 강화, 대중의 인식 개선 캠페인, 기술 제공업체와 의료기관의 전략적 협력이 필요합니다.

기술 발전은 예방 의료를 어떻게 강화할 것인가?

기술 혁신은 예방적 헬스케어 혁명의 최전선에 있으며, 보다 정확하고 효율적이며 개인화된 건강 개입을 가능하게 합니다. 인공지능과 빅데이터 분석의 통합은 질병 예측 모델을 개선하여 의료 전문가가 고위험군을 식별하고 조기 개입 전략을 실행할 수 있도록 돕고 있습니다. 웨어러블 헬스 트래커와 스마트 의료기기를 통해 소비자들은 심박수, 혈압, 혈당 수치 등 주요 건강 지표를 모니터링하고, 예방 의료를 위한 실시간 피드백을 제공받을 수 있게 되었습니다. 원격의료 및 디지털 헬스 플랫폼은 원격진료, 디지털 건강 코칭, AI 기반 진단을 촉진하여 예방 서비스에 대한 접근성을 더욱 확대하고 있습니다. 유전체 의료와 예측 바이오마커 분석은 유전적 소인을 파악하여 맞춤형 예방 전략을 가능하게함으로써 맞춤형 헬스케어에 혁명을 일으키고 있습니다. 또한, 블록체인 기술은 안전한 의료 데이터 공유를 위해 검토되고 있으며, 환자의 프라이버시를 보장하면서 데이터 중심의 예방적 헬스케어 솔루션을 개선하고 있습니다. 이러한 기술이 계속 발전함에 따라 예방 의료는 더욱 효과적이고 비용 효율적이며 전 세계 사람들이 널리 이용할 수 있게 될 것입니다.

예방적 헬스케어 기술 및 서비스 시장의 성장 동력은?

예방 의료 기술 및 서비스 시장의 성장은 만성질환 예방에 대한 인식의 증가, 진단 기술의 발전, 디지털 헬스 솔루션의 확대 등 여러 요인에 의해 이루어지고 있습니다. 웨어러블 헬스 기술과 AI를 활용한 예측 분석의 도입이 증가하면서 맞춤형 예방 의료에 대한 수요가 가속화되고 있습니다. 질병의 조기 발견과 백신 접종 프로그램을 추진하는 정부 정책은 특히 의료 인프라가 잘 갖춰진 선진 지역에서의 시장 확대를 더욱 부추기고 있습니다. 기업 부문도 성장에 기여하고 있으며, 고용주들은 직원들의 건강과 생산성을 높이기 위해 웰니스 프로그램과 예방 검진에 투자하고 있습니다. 또한, 예방 의료 전략에 원격의료 서비스를 통합함으로써, 특히 원격지에서 서비스를 충분히 받지 못하는 사람들을 위한 접근성이 향상되고 있습니다. 의료 서비스 제공자, 보험사 및 소비자가 예방 의료의 장기적인 이점을 계속 인식함에 따라 이 시장은 지속적으로 성장하여 전 세계적으로 건강 및 웰니스 관리 방식을 변화시킬 것으로 예상됩니다.

부문

유형별(조기 발견 및 스크리닝 기술, 만성질환 관리 기술, 백신, 기타 유형)

조사 대상 기업 사례

  • Abbott Laboratories
  • Cerner Corporation
  • Cigna
  • Epic Systems Corporation
  • GlaxoSmithKline plc(GSK)
  • Health Catalyst
  • IBM Watson Health
  • Johnson & Johnson
  • McKesson Corporation
  • Medtronic plc
  • Merck & Co., Inc.
  • Myriad Genetics
  • NovX Systems Corp.
  • Omron Healthcare, Inc.
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi
  • Siemens Healthineers
  • Teladoc Health
  • UnitedHealth Group

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장과 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.11

Global Preventive Healthcare Technologies and Services Market to Reach US$521.1 Million by 2030

The global market for Preventive Healthcare Technologies and Services estimated at US$297.9 Million in the year 2024, is expected to reach US$521.1 Million by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Early Detection & Screening Technologies, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$199.7 Million by the end of the analysis period. Growth in the Chronic Disease Management Technologies segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$81.2 Million While China is Forecast to Grow at 13.2% CAGR

The Preventive Healthcare Technologies and Services market in the U.S. is estimated at US$81.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.2 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Preventive Healthcare Technologies and Services Market - Key Trends & Drivers Summarized

Why Is Preventive Healthcare Gaining Momentum in the Global Medical Industry?

Preventive healthcare technologies and services have witnessed substantial growth as healthcare systems shift toward proactive measures to reduce disease burden, improve patient outcomes, and lower medical costs. Unlike reactive healthcare models that focus on treating illnesses, preventive healthcare emphasizes early diagnosis, risk assessment, and lifestyle modifications to prevent chronic diseases such as diabetes, cardiovascular disorders, and cancer. With the increasing prevalence of lifestyle-related diseases, governments, insurers, and healthcare providers are prioritizing preventive strategies, including vaccination programs, early screening tools, and personalized health monitoring solutions. The rise of digital health platforms, wearable devices, and artificial intelligence-driven diagnostics has further enhanced the accessibility and accuracy of preventive healthcare. Consumers are also becoming more health-conscious, adopting wellness-focused behaviors and leveraging technology to track and manage their health. As public and private healthcare sectors continue investing in preventive measures, the global market for preventive healthcare technologies and services is set to expand, reshaping the future of healthcare delivery.

What Challenges Are Hindering the Growth of Preventive Healthcare?

Despite its advantages, the widespread adoption of preventive healthcare technologies faces multiple challenges. One of the primary barriers is the cost of advanced diagnostic tools and health screening services, which may not be affordable for all populations, particularly in low-income regions. The lack of standardized policies and reimbursement structures for preventive healthcare further limits its accessibility, as insurance providers often prioritize treatment over prevention. Additionally, patient adherence to preventive healthcare measures remains a concern, as many individuals delay screenings, ignore early symptoms, or fail to maintain regular health check-ups. The complexity of integrating preventive healthcare data across multiple platforms also presents challenges for healthcare providers, as interoperability issues between electronic health records (EHRs), digital health devices, and AI-driven analytics must be addressed. Moreover, misinformation and skepticism surrounding vaccines, preventive medications, and digital health monitoring can slow market penetration. Addressing these challenges requires increased government support, public awareness campaigns, and strategic collaborations between technology providers and healthcare institutions.

How Are Technological Advancements Enhancing Preventive Healthcare?

Technological innovation is at the forefront of the preventive healthcare revolution, enabling more precise, efficient, and personalized health interventions. The integration of artificial intelligence and big data analytics is improving disease prediction models, allowing healthcare professionals to identify high-risk individuals and implement early intervention strategies. Wearable health trackers and smart medical devices are empowering consumers to monitor key health metrics such as heart rate, blood pressure, and glucose levels, providing real-time feedback for preventive care. Telemedicine and digital health platforms are further expanding access to preventive services by facilitating remote consultations, digital health coaching, and AI-driven diagnostics. Genomic medicine and predictive biomarker analysis are revolutionizing personalized healthcare by identifying genetic predispositions to diseases, enabling tailored prevention strategies. Additionally, blockchain technology is being explored for secure health data sharing, ensuring patient privacy while improving data-driven preventive healthcare solutions. As these technologies continue to evolve, preventive healthcare will become more effective, cost-efficient, and widely accessible across global populations.

What Is Driving the Growth of the Preventive Healthcare Technologies and Services Market?

The growth in the preventive healthcare technologies and services market is driven by several factors, including increasing awareness of chronic disease prevention, advancements in diagnostic technologies, and the expansion of digital health solutions. The rising adoption of wearable health technology and AI-powered predictive analytics is accelerating the demand for personalized preventive care. Government policies promoting early disease detection and vaccination programs are further supporting market expansion, particularly in developed regions with strong healthcare infrastructure. The corporate sector is also contributing to growth, with employers investing in wellness programs and preventive screenings to enhance workforce health and productivity. Additionally, the integration of telehealth services into preventive care strategies is improving accessibility, particularly for remote and underserved populations. As healthcare providers, insurers, and consumers continue to recognize the long-term benefits of preventive healthcare, the market is expected to witness sustained growth, transforming the way health and wellness are managed globally.

SCOPE OF STUDY:

The report analyzes the Preventive Healthcare Technologies and Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Cerner Corporation
  • Cigna
  • Epic Systems Corporation
  • GlaxoSmithKline plc (GSK)
  • Health Catalyst
  • IBM Watson Health
  • Johnson & Johnson
  • McKesson Corporation
  • Medtronic plc
  • Merck & Co., Inc.
  • Myriad Genetics
  • NovX Systems Corp.
  • Omron Healthcare, Inc.
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi
  • Siemens Healthineers
  • Teladoc Health
  • UnitedHealth Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Preventive Healthcare Technologies and Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Chronic Diseases Throws the Spotlight on Proactive Risk Mitigation and Health Monitoring
    • Expansion of Digital Health Ecosystems Drives Adoption of Remote Preventive Screening and Health Management Services
    • Integration of AI and Predictive Analytics in Early Detection Platforms Strengthens Business Case for Risk-Based Interventions
    • Growth in Wearable Devices and Mobile Health Apps Spurs Continuous Personal Health Data Collection and Monitoring
    • Government-Led Public Health Campaigns and Incentives Propel Mass Adoption of Preventive Care Solutions
    • Rising Consumer Awareness Around Preventive Health and Wellness Drives Demand for Personalized Diagnostic Services
    • Increasing Penetration of Telemedicine and Virtual Consultations Expands Access to Preventive Health Technologies
    • Development of Integrated Health Information Platforms Accelerates Interoperability and Coordinated Preventive Care
    • Focus on Value-Based Healthcare Models Drives Investments in Preventive Rather Than Reactive Treatment Approaches
    • Emergence of At-Home Testing Kits and Point-of-Care Devices Generates Demand for Decentralized Screening Programs
    • Adoption of Population Health Management Platforms Expands Addressable Market for Enterprise-Scale Preventive Solutions
    • Shift Toward Genomic and Epigenetic Risk Profiling Spurs Growth in Predictive Preventive Diagnostics
    • Increased Emphasis on Immunization and Vaccine Management Strengthens Role of Preventive Services in Public Health
    • Expansion of Corporate Wellness Programs and Employee Health Benefits Drives Organizational Investments in Preventive Care
    • Growth in AI-Powered Chatbots and Virtual Coaches Enhances Patient Engagement in Preventive Health Routines
    • Regulatory Push for Preventive Screening Guidelines and Early Detection Protocols Drives Clinical Implementation
    • Integration of Behavioral and Mental Health Modules into Preventive Platforms Spurs Holistic Health Management
    • Increased Use of Cloud-Based Analytics Enhances Risk Prediction Models and Personalized Preventive Treatment Plans
    • Partnerships Between Tech Firms and Healthcare Providers Propel Innovation in Digital Preventive Health Solutions
    • Rising Health Insurance Support for Preventive Services Expands Coverage and Reduces Out-of-Pocket Burden
    • Emergence of Digital Biomarkers and Continuous Glucose Monitoring Systems Sustains Innovation in Preventive Health Monitoring
    • Challenges in Data Privacy and Regulatory Compliance Create Demand for Secure, HIPAA-Compliant Preventive Tech Platforms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preventive Healthcare Technologies and Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Early Detection & Screening Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Early Detection & Screening Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Early Detection & Screening Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chronic Disease Management Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chronic Disease Management Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Spain 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Russia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Australia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: India 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: South Korea 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Argentina 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Brazil 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Mexico 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Iran 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Israel 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Saudi Arabia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UAE 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Africa 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제